NDC properties for NDC 9 0591-3216
NDC item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
NDC item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
NDC item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
NDC item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
NDC item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
NDC item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
NDC item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
NDC item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
NDC item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |